Page 221 - Basic Monitoring in Canine and Feline Emergency Patients

ketone 2, 5–7, 12, 16–21, 88 normosol 199
ketonemia 6 Nova Prime Plus Vet 10
VetBooks.ir ketosis 16 oliguria 200, 203
ketonuria 6
kidneys 3, 36–39, 86, 156–160, 164, 165,
173–174, 199 oscillometry 35–36, 35, 40–43
osmolality 156–157, 169
oxidative phosphorylation 80
lactate 3, 7–9, 13, 17–19, 82–83, 88, 100, 149–151 oxyhemoglobin curve 73–75, 80, 92
blood testing 3, 7–9, 13, 17–19
as disease severity biomarker 17, 18
Lactate Plus monitor 7, 12 P waves 45, 50–51, 52, 54, 58–69, 59–66
lactic acidosis 17 P/F ratio 100–102, 107–108
Lambert-Beer law 76 packed cell volume/total protein (PCV/TP)1 5, 9, 14–15,
latex-enhanced immunoassay (LIA) 185 22, 23, 102, 145, 149–151, 195
left atrium:aorta (LA:Ao) ratio 140, 141 pancreatitis 136, 205
leukocytes 5, 184 parasympathetic nervous system (PNS) 46, 52
phagocytic effects 159–160 parenchyma 190
leukocytosis 169–170 partial pressure of oxygen (PO ) 71, 80, 97–98
2
leukogram 106 patient positioning (recumbency) 131–138, 134–135, 206
lipemia 169–170 pericardial sites (PCS) 138–141, 140–141, 141
lung point (pneumothorax) 140–141, 142, 145 pericardiocentesis 148
lung rockets 138–139 petechia 102, 188, 189, 191, 196
phentolamine 39
phosphatidylserine 179
magnesium 88, 170 phospholipids 187
manometer-based monitoring 199–208 phosphorus (P) 159–160
mean arterial pressure (MAP) regulation 26–31, 28, and hyper/hypophosphatemia 159–160, 160,
34–35, 41–43, 199, 204 163–165, 164, 165
megakaryocytes 177, 189, 192 piezoelectric crystals 129, 132
mentation 4, 9–10, 21–22, 36, 68, 103, 151, 157–160, plasma (PaO ) 5, 19, 80–83
2
171, 175 plasmalyte 199
metabolic acidosis 3, 85–89, 87–88, 89, 99–100, plasminogen activator inhibitor (PAI-1) 182
104–107, 107, 120, 165–166 Platelet Function AnalyzerR (PFA)-100 186
®
metabolic alkalosis 88, 89, 99, 103, 107, 166 platelets 177–197
metabolism 1–2, 4, 100 aggregometry 186, 189, 194–195
aerobic 1–2 analysis 178, 183–185, 185–186, 192–194, 193
anaerobic 3, 19, 104, 150 blood smear evaluation 185, 185–186
metabolites, arachidonic acid 29 clumping 183–184, 192–193
methemoglobin (MetHb) 75–76, 76, 80–82 count 183–184, 192–194
microhematocrit tube 5, 7 factors and integrin 177–183, 181, 184, 187–194
mitochondria 2 function tests 185–186, 194
monocytes 179 granules contents and function 178
mucous membrane (MM) 4, 14, 76, 102, 151 plug formation and phases 177–179, 179
color 14, 20–22, 43, 67–68, 81, 150–151 von Willebrand’s disease 177–181, 185–186,
mycophenolate mofetil 192, 197 189–191, 195
myocardial distension 26–27 polydipsia/polyuria 158–163
myocytes, cardiac 45, 56, 65–66, 69 polymorphic ventricular tachycardia 59
myoglobin 71 porphyrin 71–72, 72, 76
Possey Cufflator TM 122
potassium (K) 20
Nafion tubing 116 bromide 102, 169–170
neoplasia 14, 192 and hyperkalemia 160–162, 165, 166, 169–171
neuroglycopenia 2 and hypokalemia 161, 161, 165, 166
neurologic signs 157 intracellular 158
neutrophils 193 PR interval 45
nodule signs 135, 138–142, 139, 148 prednisolone 150, 197

Index 213